Point72 Europe (London) LLP Annexon, Inc. Transaction History
Point72 Europe (London) LLP
- $1.97 Billion
- Q3 2025
A detailed history of Point72 Europe (London) LLP transactions in Annexon, Inc. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 302,861 shares of ANNX stock, worth $866,182. This represents 0.05% of its overall portfolio holdings.
Number of Shares
302,861
Previous 206,798
46.45%
Holding current value
$866,182
Previous $496,000
81.85%
% of portfolio
0.05%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ANNX
# of Institutions
151Shares Held
101MCall Options Held
88.6KPut Options Held
32.5K-
Satter Management Co., L.P.7.41MShares$21.2 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$20 Million1.13% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$18 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.84MShares$16.7 Million0.0% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $136M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...